Thriva Limited has raised £1.5m ($1.9m) in seed funding from US-based venture capital firm 500 Startups Management LLC.

The UK-based digital health company plans to use the funds for expanding its product offerings.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Centogene AG has secured €25m ($28.02m) through a Series A financing round led by TVM Capital Life Science.

The German diagnostics company Centogene intends to expand its business segments with the funds.

Art Medical Ltd has secured $20m in a financing round led by Advanced Medical Technologies LLC.

See Also:

"The minimally invasive treatments developer intends to use the funds to commercialise its patented mild procedure and also provide physician training and education."

Based in Israel, Art Medical specialises in providing smart tubes for patients in ICU.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

GenMark Diagnostics Inc has announced a public offering of shares to raise $65m.

The US-based multiplex molecular diagnostic testing systems provider plans to use the stocks for general corporate purposes and to carry out research and development activities.

Vertos Medical Inc has secured $28m in a venture financing round led by MVM Life Science Partners.

The minimally invasive treatments developer intends to use the funds to commercialise its patented mild procedure and also provide physician training and education.